MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
(loss) income
-$199,031K
(14.59%↑ Y/Y)
Net loss
-$197,532K
(16.21%↑ Y/Y)
Other comprehensive
(loss) income
-$1,499K
(-155.11%↓ Y/Y)
Foreign currency
translation adjustments
$1,045K
(-14.55%↓ Y/Y)
Unrealized gain on
available for sale...
$243K
Loss before income
taxes
-$195,713K
(15.97%↑ Y/Y)
Income tax expense
$1,819K
(-36.04%↓ Y/Y)
Reclassification adjustment for
realized net gain on...
$2,787K
Interest income
$20,527K
(46.45%↑ Y/Y)
Other non-operating
income (expense), net
$2,911K
(272.55%↑ Y/Y)
Loss from operations
-$207,692K
(-3.30%↓ Y/Y)
License and other
revenue
$15,000K
Interest expense
$11,459K
(13.57%↑ Y/Y)
Research and development
$172,224K
(14.63%↑ Y/Y)
General and
administrative
$50,468K
(-0.68%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Centessa Pharmaceuticals plc (CNTA)
Centessa Pharmaceuticals plc (CNTA)